Kodiak Sciences (KOD) Retained Earnings (2017 - 2026)
Kodiak Sciences (KOD) reported Retained Earnings of -$1.6 billion for Q1 2026, down 16.64% on a YoY basis from -$1.9 billion in Q1 2025, and down 3.73% quarter-over-quarter from -$1.6 billion in Q4 2025.
Kodiak Sciences (KOD) Retained Earnings (2017 - 2026) Analysis & Trends
Kodiak Sciences has reported Retained Earnings for 10 years, with the latest figure at -$1.6 billion in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 16.64% year-over-year to -$1.6 billion; the trailing twelve-month figure through Mar 2026 stood at -$1.6 billion (down 16.64% YoY), and the FY2025 full-year result was -$1.6 billion, down 17.31% from the prior year.
- Retained Earnings for Q1 2026 stood at -$1.6 billion, down from -$1.6 billion in the prior quarter.
- The five-year high for Retained Earnings was -$96000.0 in Q1 2023, with the low at -$1.6 billion in Q1 2026.
- Historically, Retained Earnings has averaged -$1.0 billion across 5 years, with a median of -$1.2 billion in 2024.
- Annual changes were most pronounced in 2023 — Retained Earnings surged 99.99% — and 2024, when it sank 1245285.42%.
- Kodiak Sciences' Retained Earnings stood at -$892.0 million in 2022, then retreated by 29.2% to -$1.2 billion in 2023, then slipped by 15.29% to -$1.3 billion in 2024, then declined by 17.31% to -$1.6 billion in 2025, then dropped by 3.73% to -$1.6 billion in 2026.
- The last three Retained Earnings figures came in at -$1.6 billion (Q1 2026), -$1.6 billion (Q4 2025), and -$1.5 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -838.07 Mn |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - | -1.62 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.62 Bn |
| Dec 31, 2025 | -1.56 Bn |
| Sep 30, 2025 | -1.50 Bn |
| Jun 30, 2025 | -1.44 Bn |
| Mar 31, 2025 | -1.39 Bn |
| Dec 31, 2024 | -1.33 Bn |
| Sep 30, 2024 | -1.28 Bn |
| Jun 30, 2024 | -1.24 Bn |
| Mar 31, 2024 | -1.20 Bn |
| Dec 31, 2023 | -1.15 Bn |
| Sep 30, 2023 | -1.09 Bn |
| Jun 30, 2023 | -1.04 Bn |
| Mar 31, 2023 | -96,000.00 |
| Dec 31, 2022 | -892.04 Mn |
| Sep 30, 2022 | -2.51 Mn |
| Jun 30, 2022 | -1.87 Mn |
| Mar 31, 2022 | -653.93 Mn |
| Sep 30, 2021 | -465.05 Mn |
| Mar 31, 2021 | -341.67 Mn |
| Dec 31, 2020 | 53,000.00 |